Andrew Enrietti
Chief Administrative and Transformation OfficerViatris
PharmaceuticalsView Profile →Senior Vice President, Research · Regeneron Pharmaceuticals
Lori Morton is senior vice president of research at Regeneron Pharmaceuticals. She joined in 2002 and established cardiovascular, renal and fibrosis research at the company. Her work spans antibody therapeutics and newer nucleotide and gene therapy approaches.
Last reviewed: Oct 21, 2026
Senior Vice President, Research Regeneron Pharmaceuticals
Last Reviewed: October 21, 2026
Lori Morton is senior vice president of research at Regeneron Pharmaceuticals. She joined in 2002 and established cardiovascular, renal and fibrosis research at the company. Her work spans antibody therapeutics and newer nucleotide and gene therapy approaches.
Morton completed postdoctoral fellowships at Pfizer and Sloan Kettering Cancer Center before joining Regeneron in 2002.
At Regeneron, she established research in cardiovascular disease, renal disease and fibrosis. She has led discovery and development across disease areas, working with antibody therapeutics as well as nucleotide and gene therapy approaches.
She now serves as senior vice president of Research. Alongside her scientific leadership, she sponsors Women in Industry, Science & Engineering at Regeneron, the employee resource group known as WISER. That activity connects her research leadership with support for employees working in science and engineering.
Morton earned a BS from Douglass College of Rutgers University and a PhD from the University of North Carolina at Chapel Hill.